icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
A Single Dose of RG-101, a GalNAc-Conjugated Oligonucleotide Targeting miR-122, Results in Undetectable HCV RNA Levels in Chronic Hepatitis C Patients at Week 28 of Follow-up
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
M.H. van der Ree 1, J.M.L. de Vree 2, F. Stelma 1, S.B. Willemse 1, M. van der Valk 1, S. Rietdijk 1,3, R. Molenkamp 4, J. Schinkel 4, S. Hadi 5, M. Harbers 5, A. van Vliet 5, J. Udo de Haes 5, P. Grint 6, S. Neben 6, N. Gibson 6 and H.W. Reesink 1
1. Dep. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
2. Dep. of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands
3. Dep. of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
4. Dep. of Medical Microbiology, Clinical Virology Laboratory, Academic Medical Center, Amsterdam, The Netherlands
5. PRA Healthsciences, Zuidlaren, The Netherlands
6. Regulus Therapeutics, San Diego, CA, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif